300 related articles for article (PubMed ID: 22792139)
1. Overexpression of parkin ameliorates dopaminergic neurodegeneration induced by 1- methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice.
Bian M; Liu J; Hong X; Yu M; Huang Y; Sheng Z; Fei J; Huang F
PLoS One; 2012; 7(6):e39953. PubMed ID: 22792139
[TBL] [Abstract][Full Text] [Related]
2. Inactivation of Pink1 gene in vivo sensitizes dopamine-producing neurons to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and can be rescued by autosomal recessive Parkinson disease genes, Parkin or DJ-1.
Haque ME; Mount MP; Safarpour F; Abdel-Messih E; Callaghan S; Mazerolle C; Kitada T; Slack RS; Wallace V; Shen J; Anisman H; Park DS
J Biol Chem; 2012 Jun; 287(27):23162-70. PubMed ID: 22511790
[TBL] [Abstract][Full Text] [Related]
3. Cinnamon treatment upregulates neuroprotective proteins Parkin and DJ-1 and protects dopaminergic neurons in a mouse model of Parkinson's disease.
Khasnavis S; Pahan K
J Neuroimmune Pharmacol; 2014 Sep; 9(4):569-81. PubMed ID: 24946862
[TBL] [Abstract][Full Text] [Related]
4. α-Synuclein transgenic mice reveal compensatory increases in Parkinson's disease-associated proteins DJ-1 and parkin and have enhanced α-synuclein and PINK1 levels after rotenone treatment.
George S; Mok SS; Nurjono M; Ayton S; Finkelstein DI; Masters CL; Li QX; Culvenor JG
J Mol Neurosci; 2010 Oct; 42(2):243-54. PubMed ID: 20464527
[TBL] [Abstract][Full Text] [Related]
5. DJ-1 and Parkin modulate dopamine-dependent behavior and inhibit MPTP-induced nigral dopamine neuron loss in mice.
Paterna JC; Leng A; Weber E; Feldon J; Büeler H
Mol Ther; 2007 Apr; 15(4):698-704. PubMed ID: 17299411
[TBL] [Abstract][Full Text] [Related]
6. MPTP and DSP-4 susceptibility of substantia nigra and locus coeruleus catecholaminergic neurons in mice is independent of parkin activity.
Thomas B; von Coelln R; Mandir AS; Trinkaus DB; Farah MH; Leong Lim K; Calingasan NY; Flint Beal M; Dawson VL; Dawson TM
Neurobiol Dis; 2007 May; 26(2):312-22. PubMed ID: 17336077
[TBL] [Abstract][Full Text] [Related]
7. Attenuation of MPTP-induced neurotoxicity and behavioural impairment in NSE-XIAP transgenic mice.
Crocker SJ; Liston P; Anisman H; Lee CJ; Smith PD; Earl N; Thompson CS; Park DS; Korneluk RG; Robertson GS
Neurobiol Dis; 2003 Mar; 12(2):150-61. PubMed ID: 12667469
[TBL] [Abstract][Full Text] [Related]
8. Parkin-knockout mice did not display increased vulnerability to intranasal administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
Aguiar AS; Tristão FS; Amar M; Chevarin C; Lanfumey L; Mongeau R; Corti O; Prediger RD; Raisman-Vozari R
Neurotox Res; 2013 Aug; 24(2):280-7. PubMed ID: 23588969
[TBL] [Abstract][Full Text] [Related]
9. Chronic administration of cholesterol oximes in mice increases transcription of cytoprotective genes and improves transcriptome alterations induced by alpha-synuclein overexpression in nigrostriatal dopaminergic neurons.
Richter F; Gao F; Medvedeva V; Lee P; Bove N; Fleming SM; Michaud M; Lemesre V; Patassini S; De La Rosa K; Mulligan CK; Sioshansi PC; Zhu C; Coppola G; Bordet T; Pruss RM; Chesselet MF
Neurobiol Dis; 2014 Sep; 69():263-75. PubMed ID: 24844147
[TBL] [Abstract][Full Text] [Related]
10. Recovery of hypothalamic tuberoinfundibular dopamine neurons from acute toxicant exposure is dependent upon protein synthesis and associated with an increase in parkin and ubiquitin carboxy-terminal hydrolase-L1 expression.
Benskey M; Behrouz B; Sunryd J; Pappas SS; Baek SH; Huebner M; Lookingland KJ; Goudreau JL
Neurotoxicology; 2012 Jun; 33(3):321-31. PubMed ID: 22342763
[TBL] [Abstract][Full Text] [Related]
11. Parkin-mediated protection of dopaminergic neurons in a chronic MPTP-minipump mouse model of Parkinson disease.
Yasuda T; Hayakawa H; Nihira T; Ren YR; Nakata Y; Nagai M; Hattori N; Miyake K; Takada M; Shimada T; Mizuno Y; Mochizuki H
J Neuropathol Exp Neurol; 2011 Aug; 70(8):686-97. PubMed ID: 21760537
[TBL] [Abstract][Full Text] [Related]
12. Surprising behavioral and neurochemical enhancements in mice with combined mutations linked to Parkinson's disease.
Hennis MR; Marvin MA; Taylor CM; Goldberg MS
Neurobiol Dis; 2014 Feb; 62():113-23. PubMed ID: 24075852
[TBL] [Abstract][Full Text] [Related]
13. Alpha-synuclein up-regulation in substantia nigra dopaminergic neurons following administration of the parkinsonian toxin MPTP.
Vila M; Vukosavic S; Jackson-Lewis V; Neystat M; Jakowec M; Przedborski S
J Neurochem; 2000 Feb; 74(2):721-9. PubMed ID: 10646524
[TBL] [Abstract][Full Text] [Related]
14. Genetic reduction of mitochondrial complex I function does not lead to loss of dopamine neurons in vivo.
Kim HW; Choi WS; Sorscher N; Park HJ; Tronche F; Palmiter RD; Xia Z
Neurobiol Aging; 2015 Sep; 36(9):2617-27. PubMed ID: 26070241
[TBL] [Abstract][Full Text] [Related]
15. Melatonin enhances L-DOPA therapeutic effects, helps to reduce its dose, and protects dopaminergic neurons in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice.
Naskar A; Prabhakar V; Singh R; Dutta D; Mohanakumar KP
J Pineal Res; 2015 Apr; 58(3):262-74. PubMed ID: 25626558
[TBL] [Abstract][Full Text] [Related]
16. Sigma-1 receptor regulates mitophagy in dopaminergic neurons and contributes to dopaminergic protection.
Wang M; Wan C; He T; Han C; Zhu K; Waddington JL; Zhen X
Neuropharmacology; 2021 Sep; 196():108360. PubMed ID: 33122030
[TBL] [Abstract][Full Text] [Related]
17. Nigral overexpression of alpha-synuclein in the absence of parkin enhances alpha-synuclein phosphorylation but does not modulate dopaminergic neurodegeneration.
Van Rompuy AS; Oliveras-Salvá M; Van der Perren A; Corti O; Van den Haute C; Baekelandt V
Mol Neurodegener; 2015 Jun; 10():23. PubMed ID: 26099628
[TBL] [Abstract][Full Text] [Related]
18. Sensitivity to MPTP is not increased in Parkinson's disease-associated mutant alpha-synuclein transgenic mice.
Rathke-Hartlieb S; Kahle PJ; Neumann M; Ozmen L; Haid S; Okochi M; Haass C; Schulz JB
J Neurochem; 2001 May; 77(4):1181-4. PubMed ID: 11359883
[TBL] [Abstract][Full Text] [Related]
19. Behavioral and neurotransmitter abnormalities in mice deficient for Parkin, DJ-1 and superoxide dismutase.
Hennis MR; Seamans KW; Marvin MA; Casey BH; Goldberg MS
PLoS One; 2013; 8(12):e84894. PubMed ID: 24386432
[TBL] [Abstract][Full Text] [Related]
20. Bacterial artificial chromosome transgenic mice expressing a truncated mutant parkin exhibit age-dependent hypokinetic motor deficits, dopaminergic neuron degeneration, and accumulation of proteinase K-resistant alpha-synuclein.
Lu XH; Fleming SM; Meurers B; Ackerson LC; Mortazavi F; Lo V; Hernandez D; Sulzer D; Jackson GR; Maidment NT; Chesselet MF; Yang XW
J Neurosci; 2009 Feb; 29(7):1962-76. PubMed ID: 19228951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
